Published in Eur J Cancer on January 01, 1993
Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg (1995) 1.07
Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients. Br J Cancer (2004) 0.95
Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer. Br J Cancer (1998) 0.84
Primary chemotherapy in breast cancer: The beginning of the end or the end of the beginning for the surgical oncologist? World J Surg Oncol (2003) 0.81
Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer. Br J Cancer (1996) 0.81
TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy. Acta Oncol (2014) 0.80
A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer. Br J Cancer (1995) 0.79
Preoperative chemotherapy: where do we go from here? Ann Surg (1995) 0.75
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet (2005) 11.05
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ (1990) 10.93
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Br Med J (Clin Res Ed) (1986) 5.37
Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet (1976) 4.53
Carcinoid tumour. Lancet (1998) 4.52
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50
Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology (1974) 3.97
Psychological effects of being offered choice of surgery for breast cancer. BMJ (1994) 3.48
Do we need informed consent? Lancet (1986) 3.02
Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet (1980) 2.82
In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. Nature (1976) 2.77
Is screening for cancer worth while? Results from a well-woman clinic for cancer detection. Br Med J (1970) 2.75
Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentricity? Lancet (1998) 2.70
Breast cancer, desmoid tumours, and familial adenomatous polyposis--a unifying hypothesis. Lancet (1993) 2.69
Infectious complications of subcutaneous interleukin-2 and interferon-alpha. Lancet (1992) 2.65
Primary management of carcinoma of the breast. Lancet (1993) 2.59
Screening for breast cancer, time to think--and stop? Lancet (1995) 2.58
Electron microscopic and biochemical study of lipoprotein synthesis in the isolated perfused rat liver. J Lipid Res (1967) 2.58
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50
Platinum-based chemotherapy in triple-negative breast cancer. Ann Oncol (2008) 2.46
Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol (2006) 2.40
Structural organization and functional analysis of centromeric DNA in the fission yeast Schizosaccharomyces pombe. Mol Cell Biol (1988) 2.37
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep (1987) 2.37
Clinical syndromes of mastalgia. Lancet (1976) 2.35
Mass screening for cancer of the breast. Lancet (1968) 2.33
Hypertrophy of the agranular endoplasmic reticulum in hamster liver induced by phenobarbital (with a review on the functions of this organelle in liver). J Histochem Cytochem (1966) 2.31
Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet (1998) 2.27
Nucleotide sequence analysis of a transposon (Tn5393) carrying streptomycin resistance genes in Erwinia amylovora and other gram-negative bacteria. J Bacteriol (1993) 2.18
Is clinical breast examination an acceptable alternative to mammographic screening? BMJ (2000) 2.18
Familial cancer syndromes. Lancet (1994) 2.16
Oestrogen as a reticuloendothelial stimulant in patients with cancer. Br Med J (1971) 2.14
Can results from clinical trials be generalized? Nat Med (1995) 2.13
A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin Exp Res (1997) 2.13
A colony-forming assay for human tumour xenografts using agar in diffusion chambers. Br J Cancer (1976) 2.11
Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J Lipid Res (1972) 2.07
Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res (1995) 2.05
Time to abandon TNM staging of breast cancer? Lancet (1992) 2.05
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol (1994) 2.02
A prospective evaluation of the clinical utility of the lower-extremity injury-severity scores. J Bone Joint Surg Am (2001) 1.99
Cellular uptake and nuclear binding of insulin in human cultured lymphocytes: evidence for potential intracellular sites of insulin action. Proc Natl Acad Sci U S A (1977) 1.97
Autoregulation of tubulin synthesis in hepatocytes and fibroblasts. J Cell Biol (1985) 1.95
Interaction of insulin with Pseudomonas pseudomallei. Infect Immun (1993) 1.95
Distribution of tetracycline resistance genes and transposons among phylloplane bacteria in Michigan apple orchards. Appl Environ Microbiol (1999) 1.91
Evidence for a vesicular transport mechanism in hepatocytes for biliary secretion of immunoglobulin A. Science (1980) 1.89
Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer. Br J Cancer (2004) 1.87
Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol (1995) 1.87
Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J Infect Dis (1996) 1.85
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status. Ann Oncol (2006) 1.85
Medical audit of the care of patients with epilepsy in one group practice. J R Coll Gen Pract (1980) 1.84
What are the psychological factors influencing attendance, non-attendance and re-attendance at a breast screening centre? J R Soc Med (1990) 1.83
Interobserver agreement in the classification of open fractures of the tibia. The results of a survey of two hundred and forty-five orthopaedic surgeons. J Bone Joint Surg Am (1994) 1.83
A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer (1989) 1.78
A new biological framework for cancer research. Lancet (1996) 1.73
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol (2011) 1.72
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res (1992) 1.71
Organization of clinical trial on national scale: management of early cancer of the breast. Br Med J (1972) 1.70
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer (2004) 1.69
Reticulo-endothelial activity in humans with cancer. Br J Surg (1970) 1.69
Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr (1997) 1.68
An analysis of first-time enquirers to the CancerBACUP information service: variations with cancer site, demographic status and geographical location. Br J Cancer (1999) 1.68
Breast diseases: color Doppler US in differential diagnosis. Radiology (1993) 1.67
Palliative chemotherapy for advanced non-small cell lung cancer. BMJ (1994) 1.67
Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol (1991) 1.66
Satisfaction with clinical nurse specialists in a breast care clinic: questionnaire survey. BMJ (1998) 1.66
Community-based injury prevention interventions. Future Child (2000) 1.63
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin. J Clin Oncol (2001) 1.61
Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer. Lancet (1983) 1.61
Do psychological studies upset patients? J R Soc Med (1987) 1.60
Should lymphadenectomy be discarded? I. Immunological considerations. J R Coll Surg Edinb (1973) 1.60
Carcinoma of the colon and rectum: circulating malignant cells and five-year survival. Cancer (1973) 1.60
Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum Mol Genet (1999) 1.59
Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ (1989) 1.59
The effects of surgery on tumor growth: a century of investigations. Ann Oncol (2008) 1.59
Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest (1997) 1.59
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). Ann Oncol (2005) 1.58
Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease. Br Med J (1967) 1.58
Effect of prenatal dexamethasone on rat renal development. Kidney Int (2001) 1.58
Contralateral renal abnormalities in multicystic-dysplastic kidney disease. J Pediatr (1992) 1.57
Putting the risk of breast cancer in perspective. BMJ (1998) 1.56
Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. Br Med J (1977) 1.55
Tamoxifen and contralateral breast cancer. Lancet (1985) 1.53
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group. Eur J Cancer (1997) 1.52
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy. Ann Oncol (1999) 1.51
False positive findings of mammography will have psychological consequences. BMJ (1996) 1.51
Autoradiographic localization of the sites of uptake, cellular transport, and catabolism of low density lipoproteins in the liver of normal and estrogen-treated rats. Proc Natl Acad Sci U S A (1981) 1.51
Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging. Eur J Cancer Clin Oncol (1987) 1.51
Does surgery disseminate or accelerate cancer? Lancet (1996) 1.50
Importance of mastalgia in operable breast cancer. Br Med J (Clin Res Ed) (1982) 1.49
Breast cancer in adolescents and young women. Eur J Cancer (2003) 1.49
The trials of Dr. Bernard Fisher: a European perspective on an American episode. Control Clin Trials (1997) 1.49
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration. Lancet (1994) 1.49
High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol (1995) 1.48
Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer (2005) 1.48
Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer (1990) 1.48
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme. Eur J Cancer (1990) 1.47